GSTS to host 2nd Innovation Academy on Personalized Medicine

Following the success of the inaugural event, GSTS will host the 2nd Innovation Academy on 6 December 2013 at The Royal Institution of Great Britain, London. The theme for the event is ‘Personalized medicine: Today’s reality, not just a promise for tomorrow’.

Experts in clinical science will provide insightful presentations on applications where diagnostics are already in use to provide personalized treatment. These will form three streams: therapeutic drug monitoring, infectious disease and transplantation medicine, and oncology. Fiona Carragher, Deputy Chief Scientific Officer, NHS England, will open the meeting.

Dr Dominic Harrington, Scientific Director and co-chair of the event, said, “The response to the 1st Innovation Academy was extremely positive. Clinical service is integral to everything we do at GSTS, and the Innovation Academy provides a forum for senior scientists and clinicians from across the GSTS and KingsPath partnership, to share and discuss new developments and examples of best practice.”

As the UK’s leading independent provider of pathology services, GSTS and King’s College Pathology LLP provide pathology services that make a real difference to patient care. Scientists at the Innovation Academy will showcase developments in topics such as personalizing therapy for inflammatory bowel disease, emerging technologies in virology, and patient selection for kinase inhibition in cancer.

To find out more about innovation at GSTS and KingsPath, please follow the company website link below.

To register for the 2nd Innovation Academy, email innovationacademy@gsts.com